215 related articles for article (PubMed ID: 12461079)
1. Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells.
Vlad AM; Muller S; Cudic M; Paulsen H; Otvos L; Hanisch FG; Finn OJ
J Exp Med; 2002 Dec; 196(11):1435-46. PubMed ID: 12461079
[TBL] [Abstract][Full Text] [Related]
2. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells.
Hiltbold EM; Alter MD; Ciborowski P; Finn OJ
Cell Immunol; 1999 Jun; 194(2):143-9. PubMed ID: 10383817
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice.
Ryan SO; Vlad AM; Islam K; Gariépy J; Finn OJ
Biol Chem; 2009 Jul; 390(7):611-8. PubMed ID: 19426130
[TBL] [Abstract][Full Text] [Related]
4. Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells.
Michaëlsson E; Broddefalk J; Engström A; Kihlberg J; Holmdahl R
Eur J Immunol; 1996 Aug; 26(8):1906-10. PubMed ID: 8765038
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells.
Napoletano C; Rughetti A; Agervig Tarp MP; Coleman J; Bennett EP; Picco G; Sale P; Denda-Nagai K; Irimura T; Mandel U; Clausen H; Frati L; Taylor-Papadimitriou J; Burchell J; Nuti M
Cancer Res; 2007 Sep; 67(17):8358-67. PubMed ID: 17804752
[TBL] [Abstract][Full Text] [Related]
6. Immunology of O-glycosylated proteins: approaches to the design of a MUC1 glycopeptide-based tumor vaccine.
Hanisch FG; Ninkovic T
Curr Protein Pept Sci; 2006 Aug; 7(4):307-15. PubMed ID: 16918445
[TBL] [Abstract][Full Text] [Related]
7. Cancer associated aberrant protein O-glycosylation can modify antigen processing and immune response.
Madsen CB; Petersen C; Lavrsen K; Harndahl M; Buus S; Clausen H; Pedersen AE; Wandall HH
PLoS One; 2012; 7(11):e50139. PubMed ID: 23189185
[TBL] [Abstract][Full Text] [Related]
8. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
[TBL] [Abstract][Full Text] [Related]
9. Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.
Dörfel D; Appel S; Grünebach F; Weck MM; Müller MR; Heine A; Brossart P
Blood; 2005 Apr; 105(8):3199-205. PubMed ID: 15618468
[TBL] [Abstract][Full Text] [Related]
10. O-Linked glycans control glycoprotein processing by antigen-presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cells.
Hanisch FG; Schwientek T; Von Bergwelt-Baildon MS; Schultze JL; Finn O
Eur J Immunol; 2003 Dec; 33(12):3242-54. PubMed ID: 14635032
[TBL] [Abstract][Full Text] [Related]
11. Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing.
Rughetti A; Rahimi H; Belleudi F; Napoletano C; Battisti F; Zizzari IG; Antonilli M; Bellati F; Wandall HH; Benedetti Panici P; Burchell JM; Torrisi MR; Nuti M
Cancer Immunol Res; 2014 Feb; 2(2):177-86. PubMed ID: 24778281
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells.
Hiltbold EM; Vlad AM; Ciborowski P; Watkins SC; Finn OJ
J Immunol; 2000 Oct; 165(7):3730-41. PubMed ID: 11034378
[TBL] [Abstract][Full Text] [Related]
13. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H
Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030
[TBL] [Abstract][Full Text] [Related]
14. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
15. Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes.
Ninkovic T; Kinarsky L; Engelmann K; Pisarev V; Sherman S; Finn OJ; Hanisch FG
Mol Immunol; 2009 Nov; 47(1):131-40. PubMed ID: 19007994
[TBL] [Abstract][Full Text] [Related]
16. Recombinant tumor-associated MUC1 glycoprotein impairs the differentiation and function of dendritic cells.
Rughetti A; Pellicciotta I; Biffoni M; Bäckström M; Link T; Bennet EP; Clausen H; Noll T; Hansson GC; Burchell JM; Frati L; Taylor-Papadimitriou J; Nuti M
J Immunol; 2005 Jun; 174(12):7764-72. PubMed ID: 15944279
[TBL] [Abstract][Full Text] [Related]
17. O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.
Stepensky D; Tzehoval E; Vadai E; Eisenbach L
Clin Exp Immunol; 2006 Jan; 143(1):139-49. PubMed ID: 16367945
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
Adams EW; Ratner DM; Seeberger PH; Hacohen N
Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti-beta2-glycoprotein I antibodies.
Rovere P; Sabbadini MG; Vallinoto C; Fascio U; Recigno M; Crosti M; Ricciardi-Castagnoli P; Balestrieri G; Tincani A; Manfredi AA
Arthritis Rheum; 1999 Jul; 42(7):1412-20. PubMed ID: 10403269
[TBL] [Abstract][Full Text] [Related]
20. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
